<PAGE>
EXHIBIT 99.3
[SYNAVANT LOGO]
SYNAVANT INC.
3445 PEACHTREE RD. NE, SUITE 1400
ATLANTA, GEORGIA 30326
[ ], 2000
DEAR STOCKHOLDER:
We are very pleased that you will soon be a stockholder of Synavant Inc.
("Synavant"). Synavant is the global market leader in customized Pharmaceutical
Relationship Management ("PRM") solutions and interactive marketing services,
helping pharmaceutical companies achieve maximum return on their sales and
marketing investment.
As part of IMS Health Incorporated ("IMS HEALTH"), the Synavant businesses
have been known for providing outstanding service levels and having in-depth
knowledge of the pharmaceutical market. As an independent company, our highest
priority will be to integrate the unique industry leading capabilities of the
Clark-O'Neill and IMS Health Strategic Technologies businesses to provide high
value knowledge-based solutions to the biopharmaceutical industry and healthcare
system that optimize the development, promotion and delivery of healthcare
products and services globally.
We believe that the separation of our businesses from our corporate parent,
IMS HEALTH, will provide us with greater managerial, operational and financial
focus to respond to market conditions in our business environment. For the first
time, we will have the ability to offer our employees incentive opportunities
linked to Synavant' performance as a stand-alone company, which we believe will
aid our efforts to enhance recruitment and performance.
Synavant has applied for listing of its shares on the Nasdaq National Market
under the symbol "[XXX]".
Our board, management and employees are excited about our future as an
independent company and we look forward to your support and participation in our
success.
Sincerely,
Wayne P. Yetter
Chairman and Chief Executive Officer
Synavant Inc.
